• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

线性二次模型和大多数其他常见的放射生物学模型对时间-剂量关系的预测结果相似。

The linear-quadratic model and most other common radiobiological models result in similar predictions of time-dose relationships.

作者信息

Brenner D J, Hlatky L R, Hahnfeldt P J, Huang Y, Sachs R K

机构信息

Center for Radiological Research, Columbia University, New York, New York 10032, USA.

出版信息

Radiat Res. 1998 Jul;150(1):83-91.

PMID:9650605
Abstract

One of the fundamental tools in radiation biology is a formalism describing time-dose relationships. For example, there is a need for reliable predictions of radiotherapeutic isoeffect doses when the temporal exposure pattern is changed. The most commonly used tool is now the linear-quadratic (LQ) formalism, which describes fractionation and dose-protraction effects through a particular functional form, the generalized Lea-Catcheside time factor, G. We investigate the relationship of the LQ formalism to those describing other commonly discussed radiobiological models in terms of their predicted time-dose relationships. We show that a broad range of radiobiological models are described by formalisms in which a perturbation calculation produces the standard LQ relationship for dose fractionation/protraction, including the same generalized time factor, G. This approximate equivalence holds not only for the formalisms describing binary misrepair models, which are conceptually similar to LQ, but also for formalisms describing models embodying a very different explanation for time-dose effects, namely saturation of repair capacity. In terms of applications to radiotherapy, we show that a typical saturable repair formalism predicts practically the same dependences for protraction effects as does the LQ formalism, at clinically relevant doses per fraction. For low-dose-rate exposure, the same equivalence between predictions holds for early-responding end points such as tumor control, but less so for late-responding end points. Overall, use of the LQ formalism to predict dose-time relationships is a notably robust procedure, depending less than previously thought on knowledge of detailed biophysical mechanisms, since various conceptually different biophysical models lead, in a reasonable approximation, to the LQ relationship including the standard form of the generalized time factor, G.

摘要

辐射生物学的基本工具之一是一种描述时间-剂量关系的形式体系。例如,当时间暴露模式改变时,需要可靠地预测放射治疗的等效效应剂量。目前最常用的工具是线性二次(LQ)形式体系,它通过一种特定的函数形式,即广义的 Lea-Catcheside 时间因子 G,来描述分次照射和剂量延长效应。我们根据预测的时间-剂量关系,研究了 LQ 形式体系与描述其他常见放射生物学模型的形式体系之间的关系。我们表明,广泛的放射生物学模型可以用这样的形式体系来描述,即通过微扰计算得出剂量分次/延长的标准 LQ 关系,包括相同的广义时间因子 G。这种近似等效性不仅适用于描述二元错配修复模型的形式体系,这些模型在概念上与 LQ 相似,也适用于描述对时间-剂量效应有非常不同解释的模型的形式体系,即修复能力的饱和。在放射治疗的应用方面,我们表明,在临床相关的分次剂量下,典型的可饱和修复形式体系预测的延长效应依赖性与 LQ 形式体系几乎相同。对于低剂量率照射,在诸如肿瘤控制等早期反应终点方面,预测之间同样存在等效性,但在晚期反应终点方面则不太明显。总体而言,使用 LQ 形式体系来预测剂量-时间关系是一个特别稳健的过程,对详细生物物理机制知识的依赖程度比以前认为的要小,因为各种概念上不同的生物物理模型在合理近似下会导致包括广义时间因子 G 的标准形式的 LQ 关系。

相似文献

1
The linear-quadratic model and most other common radiobiological models result in similar predictions of time-dose relationships.线性二次模型和大多数其他常见的放射生物学模型对时间-剂量关系的预测结果相似。
Radiat Res. 1998 Jul;150(1):83-91.
2
Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy.通用生存曲线和单次分割等效剂量:理解消融性放射治疗效能的有用工具。
Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):847-52. doi: 10.1016/j.ijrobp.2007.10.059.
3
The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction.线性二次模型是一种用于确定大分割剂量等效剂量的合适方法。
Semin Radiat Oncol. 2008 Oct;18(4):234-9. doi: 10.1016/j.semradonc.2008.04.004.
4
The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery.线性二次模型不适用于模拟放射外科中高单次剂量效应。
Semin Radiat Oncol. 2008 Oct;18(4):240-3. doi: 10.1016/j.semradonc.2008.04.005.
5
A LQ-based kinetic model formulation for exploring dynamics of treatment response of tumours in patients.基于 LQ 的肿瘤患者治疗反应动力学模型构建。
Z Med Phys. 2011 Sep;21(3):164-73. doi: 10.1016/j.zemedi.2010.11.001. Epub 2011 Jan 14.
6
A generalized linear-quadratic model for radiosurgery, stereotactic body radiation therapy, and high-dose rate brachytherapy.适形调强放疗、立体定向体部放疗和高剂量率近距离放疗的广义线性能量传递-二次模型。
Sci Transl Med. 2010 Jul 7;2(39):39ra48. doi: 10.1126/scitranslmed.3000864.
7
Isotope selection for permanent prostate implants? An evaluation of 103Pd versus 125I based on radiobiological effectiveness and dosimetry.永久性前列腺植入的同位素选择?基于放射生物学有效性和剂量学对¹⁰³Pd与¹²⁵I的评估。
Semin Urol Oncol. 2000 May;18(2):152-9.
8
The minimal FLASH sparing effect needed to compensate the increase of radiobiological damage due to hypofractionation for late-reacting tissues.需要最小化 FLASH 效应以补偿由于晚反应组织的分割减少导致的放射生物损伤的增加。
Med Phys. 2022 Dec;49(12):7672-7682. doi: 10.1002/mp.15911. Epub 2022 Aug 19.
9
Radiobiological modelling of dose-gradient effects in low dose rate, high dose rate and pulsed brachytherapy.低剂量率、高剂量率和脉冲近距离放射治疗中剂量梯度效应的放射生物学建模。
Phys Med Biol. 2006 Sep 7;51(17):4399-411. doi: 10.1088/0031-9155/51/17/018. Epub 2006 Aug 15.
10
Calculated and simulated effects of heterogeneous dose distributions in radiotherapy using the dose volume inhomogeneity corrected biological equivalent dose formula with special reference to prostate cancer.使用剂量体积不均匀性校正生物等效剂量公式计算和模拟放疗中不均匀剂量分布的效应,并特别提及前列腺癌。
Oncol Rep. 2007 Nov;18(5):1299-303.

引用本文的文献

1
Framework to calculate Ac, Lu, and Tb radiation dose and biological effect in metastatic castration-resistant prostate cancer treatment.计算转移性去势抵抗性前列腺癌治疗中Ac、Lu和Tb辐射剂量及生物学效应的框架。
Med Phys. 2025 Aug;52(8):e18035. doi: 10.1002/mp.18035.
2
Mathematical Modeling Unveils Optimization Strategies for Targeted Radionuclide Therapy of Blood Cancers.数学建模揭示了血液癌症靶向放射性核素治疗的优化策略。
Cancer Res Commun. 2024 Nov 1;4(11):2955-2967. doi: 10.1158/2767-9764.CRC-24-0306.
3
Particle Beam Radiobiology Status and Challenges: A PTCOG Radiobiology Subcommittee Report.
粒子束放射生物学现状与挑战:国际粒子治疗协作组放射生物学小组委员会报告
Int J Part Ther. 2024 Aug 8;13:100626. doi: 10.1016/j.ijpt.2024.100626. eCollection 2024 Sep.
4
Improved dose compensation model owing to short irradiation interruption time for hypoxic tumor using a microdosimetric kinetic model.基于微剂量动力学模型的短照射中断时间下缺氧肿瘤剂量补偿模型的改进
Rep Pract Oncol Radiother. 2024 Jul 22;29(3):271-279. doi: 10.5603/rpor.101098. eCollection 2024.
5
Mathematical Modeling Unveils Optimization Strategies for Targeted Radionuclide Therapy of Blood Cancers.数学建模揭示了血液癌症靶向放射性核素治疗的优化策略。
bioRxiv. 2024 May 23:2024.05.22.595377. doi: 10.1101/2024.05.22.595377.
6
Radiobiological evaluation considering the treatment time with stereotactic radiosurgery for brain metastases.考虑脑转移瘤立体定向放射外科治疗时间的放射生物学评估。
BJR Open. 2022 Nov 24;4(1):20220013. doi: 10.1259/bjro.20220013. eCollection 2022.
7
Predicting efficacy assessment of combined treatment of radiotherapy and nivolumab for NSCLC patients through virtual clinical trials using QSP modeling.通过 QSP 建模的虚拟临床试验预测 NSCLC 患者放化疗联合 nivolumab 治疗的疗效评估。
J Pharmacokinet Pharmacodyn. 2024 Aug;51(4):319-333. doi: 10.1007/s10928-024-09903-0. Epub 2024 Mar 17.
8
Dose Rate Effect on Cell Survival in BNCT.硼中子俘获治疗中剂量率对细胞存活的影响。
Curr Issues Mol Biol. 2023 Aug 23;45(9):6986-6994. doi: 10.3390/cimb45090441.
9
Comment on "Locoregional Failure During and After Short-Course Radiotherapy Followed by Chemotherapy and Surgery Compared to Long-Course Chemoradiotherapy and Surgery: A Five-Year Follow-Up of the RAPIDO Trial": The RAPIDO Trial Does Not Achieve Its Primary Endpoint.关于“短程放疗后序贯化疗和手术与长程放化疗和手术相比的局部区域失败情况:RAPIDO试验的五年随访”的评论:RAPIDO试验未达到其主要终点。
Ann Surg Open. 2023 Jun 2;4(2):e288. doi: 10.1097/AS9.0000000000000288. eCollection 2023 Jun.
10
High-LET radiation induces large amounts of rapidly-repaired sublethal damage.高 LET 辐射会诱导大量快速修复的亚致死损伤。
Sci Rep. 2023 Jul 11;13(1):11198. doi: 10.1038/s41598-023-38295-3.